Long-term cardiac effects of treatment for childhood leukemia

Neoplasma

Volumn 57, Issue 2, 2010, Pages 179-183

  Urbanova, D ^a   Urban, L ^b   Simkova, I ^b   Danova, K ^b   Mikuskova, E ^c   Mladosievicova, B ^a  

^a Physics and Informatics   (Slovakia)

^b NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Slovakia)

^c CANCER RESEARCH INSTITUTE   (Slovakia)

Author keywords

Anthracyclines; Cardiac troponins; Cardiotoxicity; Echocardiography; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; DAUNORUBICIN; DOXORUBICIN; TROPONIN T; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CARDIOTOXICITY; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; HEART DISEASE; HEART STROKE VOLUME; INFANT; LEUKEMIA; PRESCHOOL CHILD; SURVIVOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; INFANT; LEUKEMIA; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; STROKE VOLUME; SURVIVORS; TREATMENT OUTCOME; TROPONIN T; YOUNG ADULT;

EID: 77953640288     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_02_179     Document Type: Article

References (28)

1. SIMBRE VC, DUFFY SA, DADLANI GH, MILLER TL, LIPSHULTZ SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs. 2005; 7: 187-202. doi:10.2165/00148581-200507030-00005
2. MULROONEY DA, DOVER DC, LI S, YASUI Y, NESS KK et al. Childhood Cancer Survivor Study. Cardiovascular disease in adult 1. survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study (CCSS). Presented at the 44th Annual Meeting of the American Society of Clinical Oncology; May-June 2008; Chicago, IL.
3. PIHKALA J, SAARINEN UM, LUNDSTRÖM U, VIRTANEN K, VIRKOLA K, et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Eur J Cancer. 1996; 32A: 97-103. doi:10.1016/ 0959-8049(95)00555-2
4. KREMER LC, VAN DALEN EC, OFFRINGA M, OTTENKAMP J, VOUTE PA. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001; 19: 191-196.
5. GIANNI L, HERMAN HE, LIPSHULTZ SE, MINOTTI G, SARVAZYAN N, SAWYER DB. Anthracycline Cardiotoxicity: From Bench to Bedside. J Clin Oncol. 2008, 26: 3777-3784. doi:10.1200/JCO.2007.14.9401
6. MLADOSIEVICOVA B, FOLTINOVA A, LUPTAK I, PETRASOVA H, HULIN I. Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics. Pediatr Cardiol. 2001; 22: 478-482. doi:10.1007/ s002460010278
7. LIPSHULTZ SE, RIFAI N, SALLAN SE, LIPSITZ SR, DALTON V, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997; 96: 2641-2648.
8. HERMAN EH, ZHANG J, LIPSHULTZ SE, RIFAI N, CHADWICK D, et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol. 1999; 17: 2237-2243.
9. LIPSHULTZ SE, HINKLE AS, FRENCH CA, KOZLOWSKI AM, CONSTINE LS, et al. Accelerated atherosclerosis contributes to elevated global risk for premature symptomatic cardiovascular disease in survivors of childhood cancer. Abstract No: 3203, 39th Annual Meeting of the American Society of Clinical Oncology (ASCO); 2003 May 31-June 3; Chicago, IL.
10. CARDINALE D, SANDRI MT, MARTINONI A, TRICCA A, CIVELLI M, et al. Left ventricular dysfunction predicted by early troponin l release after high-dose chemotherapy. J Am Coll Cardiol. 2000; 36: 517-522. doi:10.1016/S0735-1097(00)00748-8
11. KILICKAP S, BARISTA I, AKGUL E, AYTEMIR K, AKSOYEK S, et al. CTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol. 2005; 16: 798-804. doi:10.1093/annonc/mdi152
12. DAUGAARD G, LASSEN U, BIE P, PEDERSEN EB, JENSEN KT, et al. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction. Eur J Heart Fail. 2005; 7: 87-93. doi:10.1016/j.ejheart.2004.03.009
13. SOKER M, KERVANCIOGLU, M. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. Saudi Med J. 2005; 26: 1197-1202.
14. GERMANAKIS I, KALMANTI M, PARTHENAKIS F, NIKITOVIC D, STIAKAKI E, et al. Correlation of plasma Nterminal probrain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int J Cardiol. 2006; 108: 212-215. doi:10.1016/j.ijcard.2005.05.006
15. BRYANT J, PICOT J, BAXTER L, LEVITT G, SULLIVAN I, et al. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. Eur J Cancer. 2007; 43: 1959-1966. doi:10.1016/j.ejca.2007.06.012
16. DOLCI A, DOMINICI R, CARDINALE D, SANDRI MT, PANTEGHINI M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008; 130: 688-695. doi:10.1309/AJCPB66LRIIVMQDR
17. URBANOVA D, URBAN L, DANOVA K, SIMKOVA I. Natriuretic peptides: biochemical markers of anthracycline cardiac toxicity? Review. Oncol Res. 2008; 17: 51-58.
18. KATUS HA, REMPPIS A, SCHEFFOLD T, DIEDERICH KW, KUEBLER W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991; 67: 1360-1367. doi:10.1016/0002-9149(91)90466-X
19. ADAMCOVA M, STERBA M, SIMUNEK T, POTACOVA A, POPELOVA O, et al. Troponin as a marker of myocardial damage in drug-induced cardiotoxicity. Expert Opin Drug Saf. 2005; 4: 457-472. doi:10.1517/14740338.4.3.457
20. BERTINCHANT JP, POLGE A, JUAN JM, OLIVA-LAURAIRE MC, GIULIANI I, et al. Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicininduced cardiomyopathy rats, and their relationship with echocardiographic and histological findings. Clin Chim Acta. 2003; 329: 39-51. doi:10.1016/S0009-8981(03)00013-5
21. KOH E, NAKAMURA T, TAKAHASHI H. Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats. Circ J. 2004; 68: 163-167. doi:10.1253/ circj.68.163
22. IPSHULTZ SE, RIFAI N, DALTON VM, LEVY DE, SILVERMAN LB, et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004; 351: 145-53.
23. MAVINKURVE-GROOTHIUS AM, KAPUSTA L. NIR A, GROOT-LOOWEN J, et al. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children. Review. Pediatr Hematol Oncol 2008,25: 655-664. doi:10.1080/08880010802244001
24. MAVINKURVE-GROOTHIUS AM, GROOT-LOONEN J. BELLERSEN L, POURIER MS, FEUTH T et al.: Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer tretated with anthracyclines. Pediatr Blood Cancer 2009, published online DOI 10.1002/pbc
25. KISMET E, VARAN A, AYABAKAN C, ALEHAN D, PORTAKAL O, et al. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer. 2004; 42: 220-224. doi:10.1002/pbc.10368
26. ROSENBERG J, SHOU M, GUSTAFSSON F, BADSKJAER J, HILDEBRANDT P et al. Prognostic threshold levels of NTproBNP testing in primary care. Eur Heart J. 2009 30 (1): 66-73. doi:10.1093/eurheartj/ehn525
27. HORACEK JM, PUDIL R, TICHY M, JEBAVY L, STRASSOVA A et al. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. Neoplasma. 2005; 52: 430-4.
28. HORACEK JM, TICHY M, PUDIL R, JEBAVY L, ZAK P et al. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation. Neoplasma. 2008; 55: 532-7.